{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:29:05Z","timestamp":1787812145728,"version":"build-2784847793"},"reference-count":10,"publisher":"Galenos Yayinevi","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tjh"],"DOI":"10.4274\/tjh.galenos.2024.2024.0055","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T09:49:37Z","timestamp":1711619377000},"page":"97-104","source":"Crossref","is-referenced-by-count":4,"title":["Management of Adult Primary Immune Thrombocytopenia: Delphi- Based Consensus Recommendations"],"prefix":"10.4274","volume":"41","author":[{"given":"Ahmet Muzaffer","family":"Demir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif G\u00fcls\u00fcm","family":"\u00dcmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhlis Cem","family":"Ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Ayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Ayl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Karaku\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahir","family":"\u00d6zkalemka\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilg\u00fcn","family":"Say\u0131nalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"S\u00f6nmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahri","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selami Ko\u00e7ak","family":"Toprak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayfur","family":"Topta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rfan","family":"Yava\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmran","family":"\u00c7al\u0131\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero","year":"2009","unstructured":"1. Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, K\u00fchne T, Ruggeri M, George JN. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;113:2386-2393.","journal-title":"Blood"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","unstructured":"2. Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, K\u00fchne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 2019;3:3829-3866.","journal-title":"Blood Adv"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","unstructured":"3. Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, Gonz\u00e1lez-L\u00f3pez TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 2019;3:3780-3817.","journal-title":"Blood Adv"},{"key":"ref3","unstructured":"4. Hsu CC, Sandford BA. The Delphi technique: Making sense of consensus. Pract Assess Res Eval 2019;12:10."},{"key":"ref4","unstructured":"5. \u015eahin AE. E\u011fitim ara\u015ft\u0131rmalar\u0131nda Delphi tekni\u011fi ve kullan\u0131m\u0131. Hacettepe \u00dcniversitesi E\u011fitim Fak\u00fcltesi Dergisi 2001;20:215-220."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1182\/bloodadvances.2023010975","article-title":"Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomised trial","volume":"8","author":"Mazzucconi","year":"2024","unstructured":"6. Mazzucconi MGG, Rodeghiero F, Avvisati G, De Stefano V, Gugliotta L, Ruggeri M, Vianelli N, Fazi P, Paoloni F, Sargentini V, Baldacci E, Ferretti A, Martino B, Vincelli ID, Carli G, Fortuna S, Di Ianni M, Ranalli P, Palandri F, Polverelli N, Lugli E, Rivolti E, Patriarca A, Rago A, D'Adda M, Gentile M, Siragusa S, Sibilla S, Carella AM, Rossi E, Battistini R, Zaja F, Bocchia M, Di Renzo N, Musto P, Crugnola M, Giuffrida AC, Krampera M, Tafuri A, Santoro C. Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomised trial. Blood Adv 2024;8:1529-1540.","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"100097","DOI":"10.1016\/j.rpth.2023.100097","article-title":"Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management","volume":"7","author":"Mahamad","year":"2023","unstructured":"7. Mahamad S, Modi D, Al-Samkari H, Cuker A, Despotovic JM, Italiano JE, Lambert MP, Lee EJ, Rondina MT, Sholzberg M, Kruse C, Larch\u00e9 M, Nazy I, Miller MS, Arnold DM. Proceedings of the immune thrombocytopenia summit: new concepts in mechanisms, diagnosis, and management. Res Pract Thromb Haemost 2023;7:100097.","journal-title":"Res Pract Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(02)07275-6","article-title":"Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial","volume":"359","author":"Godeau","year":"2002","unstructured":"8. Godeau B, Chevret S, Varet B, Lefr\u00e8re F, Zini JM, Bassompierre F, Ch\u00e8ze S, Legouffe E, Hulin C, Grange MJ, Fain O, Bierling P; French ATIP Study Group. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet 2002;359:23-29.","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1111\/jth.14809","article-title":"Management of major bleeds in patients with immune thrombocytopenia","volume":"18","author":"Mithoowani","year":"2020","unstructured":"9. Mithoowani S, Cervi A, Shah N, Ejaz R, Sirotich E, Barty R, Li N, Nazy I, Arnold DM. Management of major bleeds in patients with immune thrombocytopenia. J Thromb Haemost 2020;18:1783-1790.","journal-title":"J Thromb Haemost"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"10760296221130335","DOI":"10.1177\/10760296221130335","article-title":"Patient and physician perspectives in the management of immune thrombocytopenia in Iran: responses from the ITP World Impact Survey (I-WISh)","volume":"29","author":"Eshghi","year":"2023","unstructured":"10. Eshghi P, Abolghasemi H, Akhlaghi AA, Ashrafi F, Bordbar M, Hajifathali A, Hosseini H, Mirbehbahani N, Abedini A, Shahsavarani N, Faranoush M. Patient and physician perspectives in the management of immune thrombocytopenia in Iran: responses from the ITP World Impact Survey (I-WISh). Clin Appl Thromb Hemost 2023;29:10760296221130335.","journal-title":"Clin Appl Thromb Hemost"}],"container-title":["Turkish Journal of Hematology"],"original-title":[],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T13:49:58Z","timestamp":1717076998000},"score":1,"resource":{"primary":{"URL":"https:\/\/jag.journalagent.com\/z4\/download_fulltext.asp?pdir=tjh&plng=eng&un=TJH-95680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,5,30]]}},"URL":"https:\/\/doi.org\/10.4274\/tjh.galenos.2024.2024.0055","relation":{},"ISSN":["1300-7777","1308-5263"],"issn-type":[{"value":"1300-7777","type":"print"},{"value":"1308-5263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,30]]}}}